The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Takeda Pharma A/SEU/1/13/844/001-009

Main Information

Trade NameVipidia
Active SubstancesAlogliptin (as benzoate)
Dosage FormFilm-coated tablet
Licence HolderTakeda Pharma A/S
Licence NumberEU/1/13/844/001-009

Group Information

ATC CodeA10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH04 alogliptin


License statusAuthorised
Licence Issued19/09/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back